Element Wealth’s Teva Pharmaceuticals TEVA Stock Holding History

Element Wealth’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.03M	Hold	59,917	–	–	0.76%	27
2026 Q1	$1.8M	Hold	59,917	–	–	0.74%	30
2025 Q4	$1.87M	Buy	59,917 +4,388	+8%	+$108K	0.77%	29
2025 Q3	$1.12M	Hold	55,529	–	–	0.49%	54
2025 Q2	$931K	Hold	55,529	–	–	0.43%	56
2025 Q1	$853K	Hold	55,529	–	–	0.46%	51
2024 Q4	$1.22M	Sell	55,529 -5,000	-8%	-$91K	0.64%	34
2024 Q3	$1.09M	Sell	60,529 -5,211	-8%	-$91.2K	0.58%	36
2024 Q2	$1.07M	Hold	65,740	–	–	0.6%	33
2024 Q1	$928K	Hold	65,740	–	–	0.54%	37
2023 Q4	$686K	Buy	65,740 +52,454	+395%	+$490K	0.43%	44
2023 Q3	$136K	Sell	13,286 -15,000	-53%	-$140K	0.1%	135
2023 Q2	$213K	Buy	+28,286	New	+$229K	0.15%	121

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Element Wealth's TEVA Position: Q2 2026 in Review

Element Wealth held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 59,917 shares worth $2.03M. The position accounts for 0.76% of the portfolio, ranked #27.

Element Wealth first reported a position in TEVA in Q2 2023 and has held it in 13 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Element Wealth held 59,917 shares of Teva Pharmaceuticals worth $2.03M as of Q2 2026.
Element Wealth left its Teva Pharmaceuticals share count unchanged in Q2 2026.
Teva Pharmaceuticals made up 0.76% of Element Wealth's portfolio in Q2 2026, its #27 holding.
Element Wealth first reported a position in Teva Pharmaceuticals in Q2 2023 and has held it in 13 quarters since.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Element Wealth's 13F filing for Q2 2026, filed 14 Aug 2026.